Dr David Dodwell
David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
David is a senior breast oncologist with a number of research and governance interests.
He is the lead oncologist on the Sloane and NHS breast screening audits and co-lead for the national audits in primary and metastatic breast cancer.
Recent publications
-
The impact of the COVID-19 pandemic on the use of systemic therapy for patients diagnosed with cancer in England: A population-based study with a focus on breast and lung cancer.
Webster L. et al, (2025), Cancer Epidemiol, 96
-
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer.
Kazmi F. et al, (2025), Cochrane Database Syst Rev, 3
-
The Impact of Body Mass Index (BMI) on Clinical Outcomes for Patients Receiving Systemic Anti-Cancer Therapies for Advanced Clear Cell Renal Carcinoma.
Greene J. et al, (2025), Cancer Control, 32
-
The Assisi think tank focus review on postoperative radiation for lobular breast cancer.
Kaidar-Person O. et al, (2024), Radiother Oncol, 201
-
Survival following adjuvant trastuzumab-based treatment among older patients with HER2-positive early invasive breast cancer: A national population-based cohort study using routine data.
Gannon MR. et al, (2024), Eur J Cancer, 211